200,000+ products from a single source!
sales@angenechem.com
Home > Imidazoles > 25433-13-0
CAS No: 25433-13-0 Catalog No: AG006UUZ MDL No:MFCD01429053
Title | Journal |
---|---|
Phenylmethimazole blocks dsRNA-induced IRF3 nuclear translocation and homodimerization. | Molecules (Basel, Switzerland) 20121022 |
Phenylmethimazole inhibits production of proinflammatory mediators and is protective in an experimental model of endotoxic shock*. | Critical care medicine 20120301 |
Another potential therapeutic agent for the management of critically ill patients with sepsis syndrome: same old story, same old result?*. | Critical care medicine 20120301 |
Phenylmethimazole blocks palmitate-mediated induction of inflammatory cytokine pathways in 3T3L1 adipocytes and RAW 264.7 macrophages. | The Journal of endocrinology 20101201 |
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
Phenyl methimazole suppresses dextran sulfate sodium-induced murine colitis. | European journal of pharmacology 20100915 |
Regulation of major histocompatibility complex gene expression in thyroid epithelial cells by methimazole and phenylmethimazole. | The Journal of endocrinology 20100101 |
Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration. | Clinical cancer research : an official journal of the American Association for Cancer Research 20090615 |
Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto's autoimmune thyroiditis. | Molecular endocrinology (Baltimore, Md.) 20050501 |
Phenyl methimazole inhibits TNF-alpha-induced VCAM-1 expression in an IFN regulatory factor-1-dependent manner and reduces monocytic cell adhesion to endothelial cells. | Journal of immunology (Baltimore, Md. : 1950) 20040801 |
© 2019 Angene International Limited. All rights Reserved.